Status:

UNKNOWN

Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Primary Aldosteronism

Eligibility:

All Genders

18-80 years

Brief Summary

Primary aldosteronism (PA) is occasionally associated with impaired glucose tolerance. Glucose intolerance, in general metabolic syndrome is caused by suppression of insulin release from the pancreas ...

Detailed Description

Primary aldosteronism (PA) is occasionally associated with impaired glucose tolerance. Glucose intolerance, in general metabolic syndrome is caused by suppression of insulin release from the pancreas ...

Eligibility Criteria

Inclusion

  • Age more than 18 years old
  • Aldosteronism patients

Exclusion

  • Patients with pregnancy

Key Trial Info

Start Date :

June 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2008

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00173082

Start Date

June 1 2005

End Date

July 1 2008

Last Update

November 29 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan

Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism | DecenTrialz